Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.
J Clin Microbiol
; 42(2): 707-12, 2004 Feb.
Article
in En
| MEDLINE
| ID: mdl-14766840
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Trypanosoma cruzi
/
Membrane Glycoproteins
/
Protozoan Proteins
/
Chagas Disease
Limits:
Animals
/
Humans
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
J Clin Microbiol
Year:
2004
Document type:
Article
Affiliation country:
Country of publication: